ACP journal club - McMaster Experts

publication venue for

Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding 2003
Effects of a Hypotension-Avoidance Versus a Hypertension-Avoidance Strategy on Neurocognitive Outcomes After Noncardiac Surgery.. 178:909-920. 2025
GRADE Certainty Ratings: Thresholds Rather Than Categories of Contextualization (GRADE Guidance 41). 2025
In HF with iron deficiency, IV ferric carboxymaltose did not reduce a composite of first HF hospitalization or CV death at a median 17 mo.. 178:JC82. 2025
In active lupus nephritis, adding obinutuzumab to standard therapy increased complete renal response rates at 76 wk.. 178:JC68. 2025
In survivors of ICH with AF, DOACs reduced incident ischemic stroke and increased recurrent ICH at a median 1.4 y.. 178:JC64. 2025
Cannabis or Cannabinoids for the Management of Chronic Noncancer Pain: Best Practice Advice From the American College of Physicians.. 178:714-724. 2025
What You May Have Missed in 2024: Navigating New Medical Evidence.. 178:S1. 2025
Bleeding Risks With Non-Vitamin K Oral Anticoagulants Versus Single Antiplatelet Therapy : A Systematic Review and Meta-analysis of Randomized Trials.. 178:360-368. 2025
Guidelines International Network: Principles for Use of Artificial Intelligence in the Health Guideline Enterprise.. 178:408-415. 2025
In acute ischemic stroke with AF, early DOAC initiation was noninferior to delayed initiation for ischemic and hemorrhagic outcomes at 90 d.. 178:JC16. 2025
In asymptomatic severe AS, early TAVR vs. clinical surveillance reduced a composite of death, stroke, or CV hospitalization.. 178:JC15. 2025
In patients with ESUS, the effects of OAC and antiplatelet therapy on recurrent ischemic stroke differ across subgroups at 1 to 5 y.. 178:JC18. 2025
In rifampicin-resistant TB, bedaquiline-containing regimens reduced unfavorable status vs. a control regimen at 132 wk.. 178:JC19. 2025
In HF with mildly reduced or preserved ejection fraction, finerenone reduced worsening HF or CV death at 32 mo.. 178:JC2. 2025
Artificial Intelligence-Assisted Colonoscopy for Polyp Detection : A Systematic Review and Meta-analysis.. 177:1652-1663. 2024
Artificial Intelligence-Supported Development of Health Guideline Questions.. 177:1518-1529. 2024
Association Between Hospital Type and Resilience During COVID-19 Caseload Stress : A Retrospective Cohort Study.. 177:1370-1380. 2024
Guidelines Recommending That Clinicians Advise Patients on Lifestyle Changes: A Popular but Questionable Approach to Improve Public Health.. 177:1425-1427. 2024
In ischemic stroke treated within 4.5 h, reteplase vs. alteplase increased excellent functional outcome at 90 d.. 177:JC115. 2024
In T2DM with CKD, semaglutide reduced major kidney disease events at 3 y.. 177:JC98. 2024
Computer-Aided Diagnosis for Leaving Colorectal Polyps In Situ. 177:919-928. 2024
Reporting Conflicts of Interest and Funding in Health Care Guidelines: The RIGHT-COI&F Checklist. 177:782-790. 2024
What You May Have Missed in 2023: Keeping Up With the Constant Flow of New Medical Evidence. 177:S1-S2. 2024
In adults with ATTR cardiac amyloidosis, patisiran reduced decline in functional capacity at 12 mo. 177:JC30-JC30. 2024
In ICU patients not receiving early PN, tight and liberal glucose control did not differ for length of ICU stay or death. 177:JC8-JC8. 2024
In medical inpatients, the IMPROVE risk score had moderate predictive power for 14-d in-hospital bleeding. 177:JC11-JC11. 2024
In noncardiac thoracic surgery, low-dose colchicine did not reduce AF or myocardial injury after noncardiac surgery at 14 d. 177:JC3-JC3. 2024
In outpatients with COVID-19 during Omicron variant circulation, molnupiravir and nirmatrelvir–ritonavir improved outcomes. 177:JC7-JC7. 2024
Hypotension-Avoidance Versus Hypertension-Avoidance Strategies in Noncardiac Surgery. 176:eL230324. 2023
Hypotension-Avoidance Versus Hypertension-Avoidance Strategies in Noncardiac Surgery. 176:eL230323. 2023
Atrial Fibrillation Recurrence in Patients With Transient New-Onset Atrial Fibrillation Detected During Hospitalization for Noncardiac Surgery or Medical Illness. 176:1299-1307. 2023
In healthy older adults, low-dose aspirin increased incident anemia at a median 4.7 y. 176:JC115-JC115. 2023
Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 2). 176:1396-1404. 2023
Real-Time Computer-Aided Detection of Colorectal Neoplasia During Colonoscopy. 176:1209-1220. 2023
SGLT2 inhibitors improved health status in Black and White patients with HF regardless of race. 176:JC100-JC100. 2023
In AF, the effects of DOACs vs. warfarin on death and stroke/systemic embolism vary by baseline CrCl level. 176:JC91-JC91. 2023
In DVT, oral DTIs and factor Xa inhibitors reduce major bleeding but not recurrent VTE vs. conventional anticoagulants. 176:JC92-JC92. 2023
In adults with HF, opioids do not reduce refractory breathlessness (low-certainty evidence). 176:JC88-JC88. 2023
Medical Masks Versus N95 Respirators for Preventing COVID-19 Among Health Care Workers. 176:eL230077. 2023
Association of Low-Dose Colchicine With Incidence of Knee and Hip Replacements. 176:737-742. 2023
Comparative Efficacy and Safety of Wakefulness-Promoting Agents for Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea. 176:676-684. 2023
Hypotension-Avoidance Versus Hypertension-Avoidance Strategies in Noncardiac Surgery. 176:605-614. 2023
In type 2 MI, the T2-risk score predicted death or MI at 1 y. 176:JC58-JC58. 2023
Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19. 176:667-675. 2023
In critically ill patients with COVID-19, IL-6 receptor antagonists reduced mortality vs. control at 180 d. 176:JC41-JC41. 2023
In acute HF in the ED, a risk-based management algorithm vs. usual care reduced a composite clinical outcome at 30 d. 176:JC31-JC31. 2023
In adults with acute HF, high-intensity care vs. usual care reduced a composite of death or HF readmission at 180 d. 176:JC31-JC31. 2023
Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians. 176:224-238. 2023
The Dark Side of Rapid Reviews: A Retreat From Systematic Approaches and the Need for Clear Expectations and Reporting. 176:266-267. 2023
Monkeypox in Montréal: Epidemiology, Phylogenomics, and Public Health Response to a Large North American Outbreak. 176:67-76. 2023
Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 1). 176:115-124. 2023
In ischemic left ventricular systolic dysfunction, adding PCI to medical therapy did not reduce death or HF hospitalization. 175:JC135-JC135. 2022
Medical Masks Versus N95 Respirators for Preventing COVID-19 Among Health Care Workers. 175:1629-1638. 2022
Perioperative Safety and Early Patient and Device Outcomes Among Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Implantations. 175:1658-1665. 2022
In hospitalized adults with fever, fever therapy does not reduce mortality or serious adverse events. 175:JC127-JC127. 2022
Adult survivors of a first primary invasive cancer had increased risk for cardiovascular disease. 175:JC119-JC119. 2022
Annals Consult Guys - Perioperative Care of Patients With Hypertension. 175:CG1-CG1. 2022
In HFpEF, the benefit of empagliflozin on a composite of CV death or HF hospitalization at 26 mo did not vary by diabetes status. 175:JC111-JC111. 2022
In adults hospitalized with COVID-19, adding baricitinib vs. dexamethasone to remdesivir did not differ for MV-free survival. 175:JC115-JC115. 2022
Patient-Reported Outcome Measures in Cardiovascular Disease: An Evidence Map of the Psychometric Properties of Health Status Instruments. 175:1431-1439. 2022
Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma. 175:1310-1321. 2022
A Framework for the Development of Living Practice Guidelines in Health Care. 175:1154-1160. 2022
In AF, CV benefits of catheter ablation vs. medical therapy may vary by age. 175:JC77-JC77. 2022
Adults with first-time nephrotic syndrome had increased risk for thromboembolic events, higher near time of diagnosis. 175:JC70-JC70. 2022
In HF with mitral regurgitation, adding transcatheter mitral valve repair to medical therapy improved renal outcomes at 2 y. 175:JC65-JC65. 2022
In nonischemic systolic HF, prophylactic ICDs did not reduce all-cause mortality vs. usual care at 10 y. 175:JC66-JC66. 2022
Sodium–Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure. 175:851-861. 2022
A Reporting Tool for Adapted Guidelines in Health Care: The RIGHT-Ad@pt Checklist. 175:710-719. 2022
In high-risk outpatients with COVID-19, remdesivir reduced COVID-19–related hospitalization or all-cause death at 28 d. 175:JC50-JC50. 2022
Integrating Quality Assurance and Quality Improvement With Guidelines: Systematic Stakeholder-Driven Development of an Extension of the Guidelines International Network–McMaster Guideline Development Checklist. 175:735-739. 2022
Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2, Update Alert 3). 175:W55-W57. 2022
The Epidemiology of Thrombosis With Thrombocytopenia Syndrome: Analogies With Heparin-Induced Thrombocytopenia. 175:604-605. 2022
What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 2). 175:556-565. 2022
Colonoscopy for Diagnostic Evaluation and Interventions to Prevent Recurrence After Acute Left-Sided Colonic Diverticulitis: A Clinical Guideline From the American College of Physicians. 175:416-431. 2022
In COVID-19, escalated- vs. prophylactic-dose anticoagulation does not reduce mortality and increases major bleeding. 175:JC18-JC18. 2022
In critically ill adults, IV fluid bolus infused at slower vs. faster rates did not differ for 90-d mortality. 175:JC23-JC23. 2022
Safety and Efficiency of Diagnostic Strategies for Ruling Out Pulmonary Embolism in Clinically Relevant Patient Subgroups. 175:244-255. 2022
Performance of the European Society of Cardiology 0/1-Hour, 0/2-Hour, and 0/3-Hour Algorithms for Rapid Triage of Acute Myocardial Infarction. 175:101-113. 2022
Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation. 175:29-35. 2022
Update Alert 3: Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19. 175:W6-W7. 2022
In rotator cuff disorder, progressive exercise vs. physiotherapy advice, with or without corticosteroid injection, did not differ at 12 mo. 174:JC137-JC137. 2021
Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2). 174:W116-W117. 2021
In patients hospitalized for COVID-19, tocilizumab reduces mortality at 28 d. 174:JC125-JC125. 2021
In pregnant women with suspected VTE and low/intermediate or unlikely pretest probability, D-dimer rules out VTE at 3 mo. 174:JC130-JC130. 2021
Will QUADAS-C Make a Complicated Task Less Complex?. 174:1624-1625. 2021
Evidence and Precaution for Legal Health Interventions: Learning From the COVID-19 Pandemic. 174:1456-1457. 2021
In patients hospitalized with COVID-19, adding convalescent plasma to usual care did not reduce 28-d mortality. 174:JC113-JC113. 2021
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism. 174:1420-1429. 2021
Midodrine for the Prevention of Vasovagal Syncope. 174:1349-1356. 2021
In adults hospitalized with COVID-19, the 5-variable SOARS score predicted in-hospital mortality. 174:JC95-JC95. 2021
In patients with COVID-19, viral shedding time is 17 d and varies in some subgroups. 174:JC94-JC94. 2021
The Development of Living, Rapid Practice Points: Summary of Methods From the Scientific Medical Policy Committee of the American College of Physicians. 174:1126-1132. 2021
Appropriate Use of Point-of-Care Ultrasonography in Patients With Acute Dyspnea in Emergency Department or Inpatient Settings: A Clinical Guideline From the American College of Physicians. 174:985-993. 2021
In healthy older adults, daily aspirin increased cancer mortality. 174:JC74-JC74. 2021
Annals Graphic Medicine - Last Human Contact in COVID-19. 174:W58-W59. 2021
Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice From the American College of Physicians.. 174:822-827. 2021
In COVID-19, tocilizumab reduces all-cause mortality at 28 d. 174:JC63-JC63. 2021
In HFrEF, adding empagliflozin to medical therapy reduced a composite outcome, regardless of CKD status. 174:JC68-JC68. 2021
What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 1). 174:828-835. 2021
Clinical Practice Guidelines Registry: Toward Reducing Duplication, Improving Collaboration, and Increasing Transparency. 174:705-707. 2021
In South Africa, a 2-dose Oxford/AZ vaccine did not prevent mild to moderate COVID-19 (cases mainly B.1.351 variant). 174:JC50-JC50. 2021
Nonpharmacologic and Pharmacologic Management of Acute Pain From Non–Low Back, Musculoskeletal Injuries in Adults. 174:733-733. 2021
Clinician Perspectives on Caring for Dying Patients During the Pandemic. 174:493-500. 2021
Cloth Masks May Prevent Transmission of COVID-19. 174:580-580. 2021
In acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 y. 174:JC45-JC45. 2021
Joint testing of IgM and IgG has high value for ruling in SARS-CoV-2 infection. 174:JC47-JC47. 2021
Annals for Hospitalists Inpatient Notes - Timely Hip Fracture Surgery. 174:HO2-HO3. 2021
In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose. 174:JC29-JC29. 2021
In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 ≥14 d after the 2nd dose. 174:JC28-JC28. 2021
Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1). 174:229-236. 2021
The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose. 174:JC15-JC15. 2021
Tocilizumab did not reduce hypoxemic respiratory failure or death in hospitalized patients with COVID-19. 174:JC16-JC16. 2021
Efficacy and safety of dapagliflozin were similar in patients with type 2 DM and atherosclerotic CVD, regardless of PAD. 174:JC10-JC10. 2021
Newly prescribed canagliflozin vs. GLP-1 agonists was linked to amputation in older adults with type 2 DM and CVD. 174:JC11-JC11. 2021
World Health Organization Guidelines on Treatment of Hepatitis C Virus Infection: Best Practice Advice From the American College of Physicians.. 174:98-100. 2021
Developing Guidelines Before, During, and After the COVID-19 Pandemic. 173:1012-1014. 2020
Update Alert 2: Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19. 173:W152-W153. 2020
Chest ultrasonography by frontline physicians is more sensitive than CXR for diagnosing pneumothorax in trauma patients. 173:JC58-JC58. 2020
Point-of-care ultrasonography had 92% sensitivity and 97% specificity for diagnosing diverticulitis in the ED. 173:JC59-JC59. 2020
The Moral Imperative to Include Pregnant Women in Clinical Trials of Interventions for COVID-19. 173:836-837. 2020
Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19. 173:860-860. 2020
Association Between Bariatric Surgery and All-Cause Mortality: A Population-Based Matched Cohort Study in a Universal Health Care System. 173:694-703. 2020
Management of Acute Pain From Non–Low Back, Musculoskeletal Injuries. 173:730-738. 2020
Predictors of Prolonged Opioid Use After Initial Prescription for Acute Musculoskeletal Injuries in Adults. 173:721-729. 2020
Summary for Patients: Association Between Bariatric Surgery and All-Cause Mortality. 173:I-22. 2020
USPSTF recommends asking adults screening questions about unhealthy drug use. 173:JC38-JC38. 2020
Use of N95, Surgical, and Cloth Masks to Prevent COVID-19 in Health Care and Community Settings: Living Practice Points From the American College of Physicians (Version 1). 173:642-649. 2020
Cloth Masks May Prevent Transmission of COVID-19: An Evidence-Based, Risk-Based Approach. 173:489-491. 2020
Conversion of Urine Protein–Creatinine Ratio or Urine Dipstick Protein to Urine Albumin–Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis. 173:426-435. 2020
The Value of Large Randomized Trials of Two Active Interventions to Define the Optimal Treatment in Patients With Acute Coronary Syndrome. 173:494-495. 2020
Update Alert: Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19. 173:W122-W122. 2020
Vericiguat reduced a composite of CV death or HF hospitalization in patients with HF and reduced LVEF. 173:JC30-JC30. 2020
Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19. 173:204-216. 2020
Web Exclusive. Annals Graphic Medicine - More Than MD.. 173:W57-W58. 2020
Correction: Red and Processed Meat Consumption and Risk for All-Cause Mortality and Cardiometabolic Outcomes. 173:168-168. 2020
Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians (Version 1). 173:137-142. 2020
Breast Cancer Screening and Diagnosis. 172:840-841. 2020
Preoperative N-Terminal Pro–B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery. 172:843-843. 2020
Context and Approach in Reporting Evaluations of Electronic Health Record–Based Implementation Projects. 172:S73-S78. 2020
Unprocessed Red Meat and Processed Meat Consumption. 172:639-640. 2020
Pooled RCTs: In patients with HF in sinus rhythm, β-blockers reduced mortality at GFR ≥ 30 mL/min/1.73 m². 172:JC38-JC38. 2020
Red and Processed Meat Consumption and Risk for All-Cause Mortality and Cardiometabolic Outcomes. 172:511-511. 2020
Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults. 172:508-508. 2020
Dapagliflozin reduced worsening HF or CV death in HF with reduced ejection fraction. 172:JC16-JC16. 2020
In ACS with planned invasive evaluation, prasugrel vs ticagrelor reduced a composite of death, MI, or stroke at 1 y. 172:JC5-JC5. 2020
In stable CAD with type 2 diabetes, adding ticagrelor to aspirin reduced CV events but increased major bleeding. 172:JC4-JC4. 2020
Oral fluoroquinolone was linked to mitral and aortic regurgitation compared with amoxicillin or azithromycin. 172:JC10-JC10. 2020
Preoperative N-Terminal Pro–B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery. 172:96-96. 2020
Testosterone Treatment in Adult Men With Age-Related Low Testosterone: A Clinical Guideline From the American College of Physicians. 172:126-133. 2020
Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines. 172:46-46. 2020
Compassionate End-of-Life Care: Mixed-Methods Multisite Evaluation of the 3 Wishes Project. 172:1-1. 2020
Development of the European Commission Initiative on Breast Cancer Guidelines. 172:72-72. 2020
Web Exclusive. Annals Graphic Medicine - More Than Suturing Wounds.. 172:W28. 2020
Bedside Optic Nerve Ultrasonography for Diagnosing Increased Intracranial Pressure. 171:896-896. 2019
Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group. 171:805-805. 2019
Effect of Lower Versus Higher Red Meat Intake on Cardiometabolic and Cancer Outcomes. 171:721-721. 2019
Health-Related Values and Preferences Regarding Meat Consumption. 171:742-742. 2019
Patterns of Red and Processed Meat Consumption and Risk for Cardiometabolic and Cancer Outcomes. 171:732-732. 2019
Red and Processed Meat Consumption and Risk for All-Cause Mortality and Cardiometabolic Outcomes. 171:703-703. 2019
Reduction of Red and Processed Meat Intake and Cancer Mortality and Incidence. 171:711-711. 2019
Review: After PCI with DESs, long- and standard-term DAPT increase some adverse outcomes vs short-term DAPT. 171:JC54-JC54. 2019
Unprocessed Red Meat and Processed Meat Consumption: Dietary Guideline Recommendations From the Nutritional Recommendations (NutriRECS) Consortium. 171:756-756. 2019
Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians. 171:643-654. 2019
Annals On Call - Making Sense of Breast Cancer Screening Guidelines. 171:OC1-OC1. 2019
Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males. 171:540-540. 2019
Pantoprazole did not reduce risk for a composite of upper gastrointestinal events in stable arterial disease. 171:JC45-JC45. 2019
Annals for Hospitalists Inpatient Notes - Rethinking Oxygen Therapy for Hospitalized Patients. 171:HO2-HO2. 2019
Screening for Breast Cancer in Average-Risk Women. 171:451-451. 2019
Cardiac Device Implantation Complications: A Gap in the Quality of Care?. 171:368-368. 2019
Methods for Development of the European Commission Initiative on Breast Cancer Guidelines. 171:273-273. 2019
Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease. 171:181-181. 2019
Review: Nonpharmacologic and pharmacologic interventions improve urinary incontinence in women. 171:JC3-JC3. 2019
Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure. 171:76-76. 2019
In high-risk patients with cancer, thromboprophylaxis with rivaroxaban did not reduce VTE events at 180 days. 170:JC67-JC67. 2019
Pooled RCTs: Lowering LDL-C levels using statins reduces major vascular events in all age groups. 170:JC65-JC65. 2019
The Development of Clinical Guidelines and Guidance Statements by the Clinical Guidelines Committee of the American College of Physicians: Update of Methods. 170:863-863. 2019
In type 2 diabetes with periodontitis, intensive periodontitis treatment improved glycemic control at 1 year. 170:JC40-JC40. 2019
Screening for Breast Cancer in Average-Risk Women: A Guidance Statement From the American College of Physicians. 170:547-560. 2019
An exercise intervention during acute hospitalization improved function and cognition at discharge in older adults. 170:JC33-JC33. 2019
In patients with previous dilated cardiomyopathy, withdrawal of HF drugs increased relapse at 6 months. 170:JC28-JC28. 2019
Review: Exercise rehabilitation improves outcomes by a small amount in chronic heart failure. 170:JC34-JC34. 2019
Review: Extra physical therapy improves some outcomes by a small amount in acute or subacute health conditions. 170:JC32-JC32. 2019
In Raynaud phenomenon, on-demand sildenafil did not reduce disability or frequency or duration of attacks. 170:JC21-JC21. 2019
A wearable cardioverter–defibrillator did not reduce arrhythmic death in MI with reduced ejection fraction. 170:JC5-JC5. 2019
Management of out-of-hospital cardiac arrest with laryngeal tube improved survival vs endotracheal intubation. 170:JC4-JC4. 2019
PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies. 170:51-51. 2019
The Potential for Troponin to Inform Prognosis in Patients With Stable Coronary Artery Disease. 169:808-808. 2018
In Barrett esophagus, high- vs low-dose esomeprazole improved clinical outcomes; aspirin vs no aspirin did not. 169:JC54-JC54. 2018
Pregabalin and the Risk for Opioid-Related Death: A Nested Case–Control Study. 169:732-732. 2018
In gluteal tendinopathy, education + exercise improved outcomes vs corticosteroid injection or wait strategy. 169:JC22-JC22. 2018
Review: Evidence is inconclusive on metabolic surgery vs medical treatment for microvascular complications in T2DM. 169:JC9-JC9. 2018
In high-risk T1DM, real-time continuous glucose monitoring vs self-monitoring reduced hypoglycemic events. 168:JC53-JC53. 2018
Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians.. 168:569-576. 2018
Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer. 168:459-459. 2018
Review: Multilevel and patient-level implementation strategies reduce BP more than usual care in hypertension. 168:JC29-JC29. 2018
Aspirin in Patients With Previous Percutaneous Coronary Intervention Undergoing Noncardiac Surgery. 168:237-237. 2018
In patients with rheumatoid arthritis, bDMARD therapy was not associated with malignant neoplasms. 168:JC23-JC23. 2018
Prognostic Accuracy of the Quick Sequential Organ Failure Assessment for Mortality in Patients With Suspected Infection. 168:266-266. 2018
PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. 169:467-473. 2018
After PCI in AF, dual antithrombotic therapy with dabigatran reduced bleeding compared with triple therapy. 167:JC70-JC70. 2017
Review: In HF with preserved EF, β-blockers reduced mortality; drug treatment overall did not. 167:JC68-JC68. 2017
In localized prostate cancer, radical prostatectomy and observation did not differ for mortality at 13 years. 167:JC53-JC53. 2017
Your Money or Your Patient's Life? Ransomware and Electronic Health Records. 167:587-587. 2017
4 hs-cTnI algorithms had high sensitivity and low failure rates for ruling out acute MI in the ED. 167:JC35-JC35. 2017
HERDOO2 identified women at low risk for recurrence after 5 to 12 mo of anticoagulation for a first unprovoked VTE. 167:JC33-JC33. 2017
High-STEACS Algorithm missed fewer patients with acute MI than the ESC Pathway in the ED. 167:JC34-JC34. 2017
In knee OA, intraarticular triamcinolone increased cartilage loss and did not differ from saline for knee pain. 167:JC27-JC27. 2017
Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer. 167:341-341. 2017
In high-risk patients with arthritis and previous upper GI bleeding, celecoxib vs naproxen reduced recurrent bleeding. 167:JC17-JC17. 2017
In older adults with subclinical hypothyroidism, levothyroxine did not improve symptoms or tiredness. 167:JC14-JC14. 2017
Benefits and Risks of Antithrombotic Therapy in Essential Thrombocythemia. 167:170-170. 2017
Computer-Aided Systematic Review Screening Comes of Age. 167:210-210. 2017
Guidelines to Limit Added Sugar Intake. 167:219-219. 2017
The Scientific Basis of Guideline Recommendations on Sugar Intake. 167:219-219. 2017
Aspirin plus clopidogrel was not linked to risk for cancer compared with aspirin alone or no antiplatelets. 167:JC10-JC10. 2017
In patients receiving DAPT after coronary stents, the PRECISE-DAPT score predicted bleeding moderately well. 167:JC11-JC11. 2017
An online exercise program plus automated coping skills training improved pain and function in chronic knee pain. 166:JC67-JC67. 2017
In severe aortic stenosis with intermediate surgical risk, TAVR was noninferior to SAVR for death or disabling stroke. 166:JC68-JC68. 2017
Resuming warfarin after intracranial hemorrhage in patients with AF was linked to reduced mortality. 166:JC70-JC70. 2017
Does Knowledge of the Coronary Anatomy Save Lives in Patients With Unstable Angina?. 166:848-848. 2017
Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians. 166:818-818. 2017
After PCI with stents for AF, adding rivaroxaban vs warfarin to antiplatelet drugs reduced bleeding. 166:JC29-JC29. 2017
In patients receiving palliative care, risperidone or haloperidol increased delirium symptoms vs placebo. 166:JC32-JC32. 2017
PCI with drug-eluting stents ≤ 12 months before surgery was linked to increased MI and cardiac death after surgery. 166:JC35-JC35. 2017
Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians.. 166:430-437. 2017
Review: 1-time ultrasonography screening reduces abdominal aortic aneurysm-related mortality and rupture. 166:JC27-JC27. 2017
Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians. 166:279-279. 2017
Primary Care Physician Volume and Quality of Diabetes Care. 166:240-240. 2017
The Scientific Basis of Guideline Recommendations on Sugar Intake. 166:257-257. 2017
In older adults with COPD, new opioid use was linked to increased risk for respiratory and all-cause mortality. 166:JC11-JC11. 2017
In patients with severe sepsis, hydrocortisone did not prevent progression to septic shock. 166:JC10-JC10. 2017
Review: Some drugs, added to hydration, prevent contrast-induced acute kidney injury. 166:JC9-JC9. 2017
A reporting tool for practice guidelines in health care: the RIGHT statement. 166:128-132. 2017
Live Attenuated Versus Inactivated Influenza Vaccine in Hutterite Children. 165:617-617. 2016
4 risk assessment models had good calibration but poor discrimination for VTE in hospitalized medical patients. 165:JC35-JC35. 2016
Review: In severe aortic stenosis, TAVI and conventional surgery do not differ for ≤ 30-day or ≤ 1-year mortality. 165:JC31-JC31. 2016
Adding candesartan-HCTZ to rosuvastatin increased adverse events but not benefits in patients at intermediate CV risk. 165:JC8-JC8. 2016
Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. 165:125-125. 2016
Principles for Disclosure of Interests and Management of Conflicts in Guidelines: Desirable and Undesirable Action and Consequences. 164:702-702. 2016
Transition care with telemonitoring did not reduce readmission after hospitalization for heart failure. 164:JC59-JC59. 2016
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia. 164:636-636. 2016
The Effect of Erythropoietin-Stimulating Agents on Health-Related Quality of Life in Anemia of Chronic Kidney Disease. 164:472-472. 2016
Evidence-Based Guideline: ACR made 10 strong treatment recommendations for RA, but high-quality evidence was sparse. 164:JC27-JC27. 2016
Restarting antithrombotics after GI bleeding was linked to better outcomes in patients with AF. 164:JC33-JC33. 2016
In older adults with treatment-resistant depression, adding aripiprazole to venlafaxine increased remission at 12 wk. 164:JC10-JC10. 2016
In HIV-1, immediate vs deferred antiretroviral therapy and isoniazid vs no isoniazid reduced severe illness at 30 mo. 163:JC5-JC5. 2015
In early HIV infection, immediate vs deferred antiretroviral therapy reduced serious illnesses at 3 years. 163:JC4-JC4. 2015
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia. 163:519-528. 2015
Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in Guidelines. 163:548-553. 2015
Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality. 163:409-416. 2015
How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Practice Tool Endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network, and the Canadian Cardiovascular Society. 163:382-385. 2015
Baseline plus 1-hour high-sensitivity cardiac troponin T improved early rule-out and rule-in of acute MI. 163:JC12-JC12. 2015
Personalizing Death in the Intensive Care Unit: The 3 Wishes Project. 163:271-279. 2015
David Lawrence Sackett, MD, MSc (Epidemiology), 1934–2015. 163:JC2-JC2. 2015
Longer- Versus Shorter-Duration Dual-Antiplatelet Therapy After Drug-Eluting Stent Placement. 163:118-126. 2015
Use of long-acting, vs short-acting, opioids for chronic pain was linked to unintentional overdose. 163:JC11-JC11. 2015
ACP Journal Club. In STEMI, manual thrombectomy before PCI did not reduce CV-related outcomes but increased stroke.. 162:JC2. 2015
How Effective Is the Medicare Part D Drug Plan?. 162:869-870. 2015
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations. 162:777-784. 2015
In hospitalized patients, an electronic alert for acute kidney injury did not differ from usual care. 162:JC6-JC6. 2015
d-Dimer Testing in Patients With a First Unprovoked Venous Thromboembolism. 162:671-671. 2015
In acute ischemic stroke, early intraarterial treatment plus usual care improved functional independence. 162:JC2-JC2. 2015
In acute ischemic stroke, rapid intraarterial treatment plus usual care improved functional independence. 162:JC3-JC3. 2015
In ischemic stroke, early intraarterial treatment plus alteplase improved reperfusion and functional outcome. 162:JC4-JC4. 2015
Review: In peri- or postmenopausal women, DHEA does not improve symptoms and increases androgenic side effects. 162:JC9-JC9. 2015
Mechanical left atrial appendage closure was noninferior and superior to warfarin in atrial fibrillation. 162:JC4-JC4. 2015
Review: In renal impairment, apixaban reduces, or does not increase, bleeding compared with other anticoagulants. 162:JC3-JC3. 2015
Cervical Spine Clearance in Obtunded Patients After Blunt Traumatic Injury. 162:429-437. 2015
Dual antiplatelets for 30 mo after drug-eluting stents reduced stent thrombosis and CV and cerebrovascular events. 162:JC9-JC9. 2015
Albumin Administration in Patients With Sepsis. 162:319-320. 2015
Platelet Transfusion: A Clinical Practice Guideline From the AABB. 162:205-213. 2015
d-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy. 162:27-34. 2015
In suspected nephrolithiasis, US did not differ from CT for high-risk diagnoses but reduced radiation exposure. 162:JC4-JC4. 2015
The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): results from a multispecialty panel using the RAND/UCLA appropriateness method. 163:S1-S40. 2015
Review: Fiber supplementation improves symptoms in the irritable bowel syndrome. 161:JC10-JC10. 2014
Review: In sepsis, the effect of resuscitation with crystalloid and colloid fluids on mortality varies. 161:JC12-JC12. 2014
Review: In pulmonary embolism, thrombolytic therapy reduces all-cause mortality but increases major bleeding. 161:JC9-JC9. 2014
Fluid Resuscitation in Sepsis. 161:347-347. 2014
Atypical Antipsychotic Drugs and the Risk for Acute Kidney Injury and Other Adverse Outcomes in Older Adults. 161:242-242. 2014
Methotrexate reduced pain and improved function in symptomatic knee osteoarthritis. 161:JC6-JC6. 2014
Review: Natriuretic peptide–guided therapy reduces mortality more than clinically guided therapy in heart failure. 161:JC10-JC10. 2014
In AF, apixaban reduced stroke or systemic embolism compared with warfarin, regardless of patient age. 160:JC7-JC7. 2014
Early high-dose rosuvastatin prevented contrast-induced acute kidney injury in non–ST-elevation ACS. 160:JC9-JC9. 2014
In anticoagulated patients with AF, HAS-BLED predicted major bleeding better than CHADS₂and CHA₂DS₂-VASc. 160:JC13-JC13. 2014
Live kidney donation was associated with increased mortality and end-stage renal disease at 15 years. 160:JC12-JC12. 2014
Review: Calprotectin testing differentiates inflammatory bowel disease from the irritable bowel syndrome. 160:JC13-JC13. 2014
Adding lisinopril to losartan increased hyperkalemia and acute kidney injury in type 2 diabetes and proteinuria. 160:JC3-JC3. 2014
Review: New oral anticoagulants increase GI bleeding in venous thrombosis and ACS. 160:JC4-JC4. 2014
Review: Novel oral anticoagulants reduce stroke more than ASA in nonvalvular atrial fibrillation. 160:JC3-JC3. 2014
Lipid Management in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2013 Clinical Practice Guideline. 160:182-189. 2014
Methylprednisolone injections reduced carpal tunnel syndrome symptoms at 10 weeks and surgery at 1 year. 160:JC11-JC11. 2014
Review: Bariatric surgery increases weight loss and diabetes remission more than nonsurgical treatment. 160:JC7-JC7. 2014
In intermediate-risk acute PE, tenecteplase plus heparin reduced hemodynamic decompensation but increased stroke.. 161:JC8-JC8. 2014
Crohn disease was not associated with increased risk for mortality. 159:JC12-JC12. 2013
Review: Probiotics preventC. difficile–associated diarrhea in patients using antibiotics. 159:JC7-JC7. 2013
Statin Toxicity From Macrolide Antibiotic Coprescription. 159:575-575. 2013
Patent foramen ovale closure and medical therapy did not differ for recurrence after cryptogenic embolism. 159:JC5-JC5. 2013
Patent foramen ovale closure and medical therapy did not differ for recurrence after cryptogenic stroke. 159:JC4-JC4. 2013
Review: Treatment options for asymptomatic carotid artery stenosis were compared. 159:JC6-JC6. 2013
Review: Routine venous thromboembolism prophylaxis in hospitalized frail older patients has uncertain benefit. 159:JC9-JC9. 2013
Statin Toxicity From Macrolide Antibiotic Coprescription. 158:869-869. 2013
Aspirin Versus Low-Molecular-Weight Heparin for Extended Venous Thromboembolism Prophylaxis After Total Hip Arthroplasty. 158:800-800. 2013
Review: Blood transfusions are associated with higher mortality than no or restricted transfusions in MI. 158:JC13-JC13. 2013
Review: Nutritional supplementation has uncertain effects on patient-important outcomes in COPD. 158:JC5-JC5. 2013
Review: Probiotics reduceClostridium difficile–associated diarrhea in patients receiving antibiotics. 158:JC10-JC10. 2013
Probiotics for the Prevention ofClostridium difficile–Associated Diarrhea. 158:706-706. 2013
Adding renal dysfunction to CHADS₂did not improve prediction of stroke or systemic embolism in AF. 158:JC13-JC13. 2013
Aspirin did not reduce recurrence after a first-ever, unprovoked venous thromboembolism. 158:JC2-JC2. 2013
Chlorthalidone Versus Hydrochlorothiazide for the Treatment of Hypertension in Older Adults. 158:447-447. 2013
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma. 158:329-329. 2013
The PLAN score predicted death and severe disability in patients with acute ischemic stroke. 158:JC13-JC13. 2013
Review: Case management reduces mortality and HF readmissions in patients with HF. 158:JC11-JC11. 2013
Selectived-Dimer Testing for Diagnosis of a First Suspected Episode of Deep Venous Thrombosis. 158:93-93. 2013
Probiotics for the Prevention ofClostridium difficile–Associated Diarrhea. 157:878-878. 2012
Hepatitis C Virus Testing of Persons Born During 1945–1965: Recommendations From the Centers for Disease Control and Prevention. 157:817-817. 2012
rt-PA within 6 hours of acute ischemic stroke did not improve clinical outcomes at 6 months. 157:JC5-JC5. 2012
Screening Women for Intimate Partner Violence. 157:676-676. 2012
Review: Oseltamivir relieves symptoms but does not reduce hospitalizations in influenza. 157:JC3-JC3. 2012
Antivirals for Treatment of Influenza. 157:386-386. 2012
Effects of Excessive Fructose Intake on Health. 156:905-905. 2012
Effects of Excessive Fructose Intake on Health. 156:905-905. 2012
Hypnotic drugs were associated with increased risk for mortality. 156:JC6-JC6. 2012
Review: Perioperative statins reduce perioperative MI and AF in statin-naïve patients. 156:JC6-JC6. 2012
Conflicts of Interest Ethics: Silencing Expertise in the Development of International Clinical Practice Guidelines. 156:809-809. 2012
Inviting Patients to Read Doctors' Notes. 156:608-608. 2012
Effect of Fructose on Body Weight in Controlled Feeding Trials. 156:291-291. 2012
Effects of School Closure on Incidence of Pandemic Influenza in Alberta, Canada. 156:173-173. 2012
Sex Differences in Implantable Cardioverter-Defibrillator Outcomes: Findings From a Prospective Defibrillator Database. 156:195-195. 2012
Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. 156:512-524. 2012
Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis. 156:710-719. 2012
Correction: Whole-Body Vibration. 155:860-860. 2011
Effect of 12 Months of Whole-Body Vibration Therapy on Bone Density and Structure in Postmenopausal Women. 155:668-668. 2011
Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS_2 Score: A Subgroup Analysis of the RE-LY Trial. 155:660-660. 2011
Warfarin Dose Assessment Every 4 Weeks Versus Every 12 Weeks in Patients With Stable International Normalized Ratios. 155:653-653. 2011
Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable. 155:579-579. 2011
Outpatient treatment was noninferior to inpatient treatment for preventing recurrent VTE in low-risk patients with acute PE. 155:JC4-JC4. 2011
Perioperative Myocardial Infarction in Patients Undergoing Noncardiac Surgery. 155:477-477. 2011
Annual screening with CA-125 and transvaginal ultrasonography did not reduce ovarian cancer incidence or mortality. 155:JC3-JC3. 2011
Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From Uganda. 155:209-209. 2011
Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. 155:179-179. 2011
The Wells rule and a primary care rule were useful for ruling out deep venous thrombosis in primary care. 154:JC6-JC6. 2011
Rates of Kidney Transplantation in Nations With Presumed Consent. 154:778-778. 2011
ACP journal club. Apixaban reduced VTE and did not increase major bleeding compared with enoxaparin in hip replacement.. 154:JC5-J06. 2011
In hemodialysis patients with CHF, adding telmisartan to standard ACE inhibitors reduced CHD mortality and admissions. 154:JC5-JC5. 2011
Rivaroxaban was noninferior to enoxaparin for preventing short-term recurrent VTE and superior to placebo in continued treatment. 154:JC5-JC5. 2011
Assessment of Recurrence Risk After Unprovoked Venous Thromboembolism. 154:644-644. 2011
Cholera Epidemic in Haiti, 2010: Using a Transmission Model to Explain Spatial Spread of Disease and Identify Optimal Control Interventions. 154:593-593. 2011
Comparison of Inhaled Long-Acting β-Agonist and Anticholinergic Effectiveness in Older Patients With Chronic Obstructive Pulmonary Disease. 154:583-583. 2011
Characteristics and Short-Term Prognosis of Perioperative Myocardial Infarction in Patients Undergoing Noncardiac Surgery. 154:523-523. 2011
Review: Ultrasonography is accurate for diagnosing rotator cuff tears in adults. 154:JC4-JC4. 2011
Should Patients With Stroke Wear Compression Stockings?. 154:506-506. 2011
Update in Hematology and Oncology: Evidence Published in 2010. 154:487-487. 2011
Hormone therapy increased risk for kidney stones in healthy postmenopausal women. 154:JC3-JC3. 2011
Estimated Glomerular Filtration Rate and Albuminuria as Predictors of Outcomes in Patients With High Cardiovascular Risk. 154:310-310. 2011
Review: Topical nitroglycerin reduces pain during ADL in patients with chronic tendinopathies. 154:JC2-JC2. 2011
Review: Positive D-dimer results predict recurrence after first unprovoked VTE regardless of test timing or cutpoint, or patient age. 154:JC1-JC1. 2011
Early and late initiation of dialysis did not differ for reduction of all-cause mortality in stage 5 chronic kidney disease. 153:JC5-JC5. 2010
Informing the Debate: Rates of Kidney Transplantation in Nations With Presumed Consent. 153:641-641. 2010
Should Patients With Stroke Wear Compression Stockings to Prevent Venous Thromboembolism?. 153:610-610. 2010
A 9-factor score predicted 2-year risk for bleeding in outpatients with, or at high risk for, atherothrombosis. 153:JC4-JC4. 2010
Individual and combined confrontation visual field tests performed poorly as a screen for visual field abnormalities. 153:JC4-JC4. 2010
Patient-Level Meta-analysis: Effect of Measurement Timing, Threshold, and Patient Age on Ability ofd-Dimer Testing to Assess Recurrence Risk After Unprovoked Venous Thromboembolism. 153:523-523. 2010
Lenient rate control is as effective as strict rate control for preventing cardiovascular events in AF. 153:JC2-JC2. 2010
Systematic Review: Factors Associated With Risk for and Possible Prevention of Cognitive Decline in Later Life. 153:182-182. 2010
Extended-Duration Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients With Recently Reduced Mobility. 153:8-8. 2010
Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease. 153:23-23. 2010
Review: Evidence on the effectiveness of sodium bicarbonate regimens to prevent contrast-induced nephropathy is unclear. 152:JC5-JC5. 2010
On-demand ordering of chest radiographs reduced the number of chest radiographs in mechanically ventilated adults. 152:JC3-JC3. 2010
Risk for postoperative venous thromboembolism in women was increased for ≥ 12 weeks and varied by type of surgery. 152:JC3-JC3. 2010
Adding revascularization to medical therapy did not improve renal function in atherosclerotic renal artery stenosis. 152:JC2-JC2. 2010
Either cholesterol or apolipoprotein levels can be used to determine risk for CVD; triglycerides are not useful. 152:JC2-JC2. 2010
Review: Neuraminidase inhibitors relieve influenza symptoms and reduce laboratory-confirmed influenza in healthy adults. 152:JC2-JC2. 2010
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding. 152:101-101. 2010
Guidelines and Conflicts of Interest. 153:422-422. 2010
The vexing problem of guidelines and conflict of interest: a potential solution. 152:738-741. 2010
A Mediterranean-style diet reduced need for glucose-lowering drugs more than a low-fat diet in type 2 diabetes. 151:JC6-JC6. 2009
New and underutilized features of ACP Journal Club PLUS and ACPJC.org: stellar articles, searches, and succinct synopses of the principles and practice of “personalized” evidence-based medicine. 151:JC6-JC6. 2009
Sensitive cardiac troponin assays were more accurate than a standard troponin assay for early diagnosis of AMI. 151:JC6-JC6. 2009
Systematic Review: Family History in Risk Assessment for Common Diseases. 151:878-878. 2009
Systematic review: family history in risk assessment for common diseases.. 151:878-885. 2009
Percutaneous closure of the left atrial appendage was noninferior to warfarin in atrial fibrillation. 151. 2009
The tough math of evidence-based health care: E × KT2 = ROI. 151:JC5-JC5. 2009
Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia. 151:622-622. 2009
Correction: Predicting Deep Venous Thrombosis in Pregnancy. 151:516-516. 2009
Redundant Data in the Meta-analysis onHelicobacter pyloriEradication. 151:513-513. 2009
3 prediction rules, particularly ABCD, identify ED patients who can be discharged with low risk for stroke after TIA. 151. 2009
Accessing preappraised evidence: fine-tuning the 5S model into a 6S model. 151:JC3-JC3. 2009
Vitamin K to Correct Overanticoagulation. 151:435-435. 2009
Comparing the USPSTF and GRADE Approaches to Recommendations. 151:363-363. 2009
Positron Emission Tomography Plus Computed Tomography for Staging Early Lung Cancer. 151:I-I. 2009
Positron Emission Tomography in Staging Early Lung Cancer. 151:221-221. 2009
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. 151:264-264. 2009
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration. 151:W-W. 2009
Predicting Deep Venous Thrombosis in Pregnancy: Out in “LEFt” Field?. 151:85-85. 2009
The devil is in the details…or not? A primer on individual patient data meta-analysis. 151:JC1-JC1. 2009
Effect of Telmisartan on Renal Outcomes. 151:1-1. 2009
“Pragmatic” clinical trials: from whose perspective?. 150:JC6-JC6. 2009
Composite Outcomes Can Distort the Nature and Magnitude of Treatment Benefits in Clinical Trials. 150:566-566. 2009
Aspirin for Prevention and Treatment of Cardiovascular Disease. 150:414-414. 2009
Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding. 150:379-379. 2009
Prednisolone, but not valacyclovir, reduced time to complete recovery of facial-nerve function in Bell palsy. 150:JC3-JC3. 2009
What does it take to put an ugly fact through the heart of a beautiful hypothesis?. 150:JC3-JC3. 2009
Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin. 150:293-293. 2009
Telmisartan did not prevent recurrent stroke or major cardiovascular events. 150:JC2-JC2. 2009
A single measure of urinary neutrophil gelatinase-associated lipocalin was accurate for diagnosing acute kidney injury.. 149:13. 2008
A single measure of urinary neutrophil gelatinase–associated lipocalin was accurate for diagnosing acute kidney injury. 149:JC6-JC6. 2008
GRADE: assessing the quality of evidence for diagnostic recommendations. 149:JC6-JC6. 2008
GRADE: assessing the quality of evidence for diagnostic recommendations.. 149:2. 2008
Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis. 149:698-698. 2008
Evidence in context: One person's poison is another's acceptable risk. 149:JC5-JC5. 2008
Evidence in context: one person's poison is another's acceptable risk.. 149:2-3. 2008
Review: Anticoagulation with INRs < 2 or between 3 and 5 increases risk for thromboembolic or hemorrhagic events. 149:JC5-JC5. 2008
Review: psychological interventions prevent depression after stroke.. 149:13. 2008
Correction: Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-analyses. 149:596-596. 2008
Systematic Review: d-Dimer to Predict Recurrent Disease after Stopping Anticoagulant Therapy for Unprovoked Venous Thromboembolism. 149:481-481. 2008
Why internal medicine subspecialists and generalists should register for ACP Journal Club PLUS. 149:JC3-JC3. 2008
The Importance of Measuring Executive Function When Studying the Effects of Cognition-Enhancing Agents. 149:359-359. 2008
Prognosis after West Nile Virus Infection. 149:232-232. 2008
Why A-level evidence does not make it to clinicians' A-lists: the case of thromboprophylaxis in medical patients. 149:JC2-JC2. 2008
Why A-level evidence does not make it to clinicians' A-lists: the case of thromboprophylaxis in medical patients.. 149:2. 2008
Correction: Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses. 149:219-219. 2008
Age, sex, and functional impairment predicted risk for mortality in incident dementia at 14 years. 149:JC1-JC1. 2008
Evidence-based medicine targets the individual patient. Part 2: Guides and tools for individual decision-making. 149:JC1-JC1. 2008
Age, sex, and functional impairment predicted risk for mortality in incident dementia at 14 years.. 149:13. 2008
Evidence-based medicine targets the individual patient. Part 2: Guides and tools for individual decision-making.. 149:1-2. 2008
Evidence-based medicine targets the individual patient. Part 1: How clinicians can use study results to determine optimal individual care. 148:JC4-JC4. 2008
Evidence-based medicine targets the individual patient. Part 1: how clinicians can use study results to determine optimal individual care.. 148:2. 2008
Intensive insulin therapy and starch (HES 200/0.5) had some risk and no clear benefit in severe sepsis.. 148:4. 2008
Low-dose hydrocortisone did not improve survival in patients with septic shock but reversed shock earlier. 148:JC4-JC4. 2008
Low-dose hydrocortisone did not improve survival in patients with septic shock but reversed shock earlier.. 148:6. 2008
Review: Azathioprine, infliximab, certolizumab, and adalimumab are effective for maintaining remission in Crohn disease. 148:JC4-JC4. 2008
Review: azathioprine, infliximab, certolizumab, and adalimumab are effective for maintaining remission in Crohn disease.. 148:9. 2008
Systematic Review: Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast Cancer. 148:671-671. 2008
Current Pharmacologic Treatment of Dementia: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians. 148:370-370. 2008
Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline. 148:379-379. 2008
6Ts Teaching Tips for evidence-based practitioners*. 148:A9-A9. 2008
Early treatment with prednisolone, but not acyclovir, promoted complete recovery of facial-nerve function in Bell palsy. 148:29-29. 2008
Heparin prophylaxis did not increase mortality and was beneficial in adults with sepsis receiving drotrecogin alfa. 148:32-32. 2008
Addition of graduated compression stockings to fondaparinux did not reduce risk for venous thromboembolism after hip surgery. 148:21-21. 2008
The Risk for Fatal Pulmonary Embolism after Discontinuing Anticoagulant Therapy for Venous Thromboembolism. 147:766-766. 2007
Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin. 147:671-671. 2007
Anticoagulant Prophylaxis for Hospitalized Medical Patients. 147:524-524. 2007
Meta-analysis: Effect of Prophylactic Hematopoietic Colony-Stimulating Factors on Mortality and Outcomes of Infection. 147:400-400. 2007
Influence of Renal Function on the Efficacy and Safety of Fondaparinux Relative to Enoxaparin in Non–ST-Segment Elevation Acute Coronary Syndromes. 147:304-304. 2007
Rituximab for Patients with Idiopathic Thrombocytopenic Purpura. 147:281-281. 2007
Surveillance for Hospital Outbreaks of Invasive Group A Streptococcal Infections in Ontario, Canada, 1992 to 2000. 147:234-234. 2007
A Red Blood Cell Agglutination d-Dimer Test to Exclude Deep Venous Thrombosis in Pregnancy. 147:165-165. 2007
Review: Flight times > 8 hours and the presence of risk factors for VTE increase travel-related VTE. 147:7-7. 2007
Ethical Issues in Stopping Randomized Trials Early Because of Apparent Benefit. 146:878-878. 2007
When My Father Died. 146:893-893. 2007
Homocysteine-Lowering Therapy and Risk for Venous Thromboembolism. 146:761-761. 2007
A communication strategy and brochure reduced the burden of bereavement on relatives of patients dying in the intensive care unit. 146:69-69. 2007
Review: Eradication therapy supplemented by probiotics increased eradication rates and reduced side effects in H. pylori infection. 146:63-63. 2007
Tiotropium in Combination with Placebo, Salmeterol, or Fluticasone–Salmeterol for Treatment of Chronic Obstructive Pulmonary Disease. 146:545-545. 2007
Adjuvant vinorelbine plus cisplatin extended survival longer than observation in resected non–small-cell lung cancer at median 76 months. 146:31-31. 2007
An abnormal D-dimer test result indicated that anticoagulation should be continued. 146:29-29. 2007
Noninferiority was not shown between stenting and endarterectomy in severe symptomatic carotid stenosis. 146:33-33. 2007
Review: Inhaled insulin provides better glycemic control than oral hypoglycemic agents but not better than subcutaneous insulin. 146:38-38. 2007
Stenting led to more stroke or death than did endarterectomy in symptomatic carotid stenosis ≥ 60%. 146:32-32. 2007
Meta-analysis: Anticoagulant Prophylaxis to Prevent Symptomatic Venous Thromboembolism in Hospitalized Medical Patients. 146:278-278. 2007
Brief Communication: Preoperative Anticoagulant Activity after Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin. 146:184-184. 2007
Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura. 146:25-25. 2007
Misunderstandings, misperceptions, and mistakes. 146:A8-A8. 2007
Interval versus Continuous High-Intensity Exercise in Chronic Obstructive Pulmonary Disease. 145:816-816. 2006
Of studies, syntheses, synopses, summaries, and systems: the “5S” evolution of information services for evidence-based health care decisions. 145:A8-A8. 2006
Oral decontamination with chlorhexidine reduced ventilator-associated pneumonia in high-risk patients. 145:68-68. 2006
Review: A low-protein diet delays end-stage renal disease or death in stage 3 to 5 chronic kidney disease. 145:64-64. 2006
Formoterol in addition to tiotropium improved airflow obstruction in chronic obstructive pulmonary disease. 145:39-39. 2006
Review: The renoprotective effects of ACE inhibitors and ARBs independent of blood pressure control are uncertain. 145:36-36. 2006
Meta-Analysis: Risk for Hypertension in Living Kidney Donors. 145:185-185. 2006
An Evaluation of d-Dimer in the Diagnosis of Pulmonary Embolism. 144:812-812. 2006
Meta-Analysis: Low-Molecular-Weight Heparin and Bleeding in Patients with Severe Renal Insufficiency. 144:673-673. 2006
Intensive insulin therapy reduced cardiovascular disease in type 1 diabetes. 144:63-63. 2006
An early invasive strategy was not better than a selectively invasive strategy for acute coronary syndromes. 144:30-30. 2006
The Canadian CT Head Rule was as sensitive as, but more specific than, the New Orleans Criteria for identifying minor head injury. 144:53-53. 2006
A simple risk score predicted 7-day stroke risk after transient ischemic attack. 144:24-24. 2006
An emerging consensus on grading recommendations?. 144:A8-A8. 2006
Management with a pulmonary artery catheter did not reduce all-cause mortality in critically ill patients. 144:21-21. 2006
Moderate-and high-intensity implementation of guidelines increased outpatient care of low-risk pneumonia. 144:80-80. 2006
Vena cava filters reduced long-term risk for pulmonary embolism in proximal deep venous thrombosis. 144:18-18. 2006
Plasma Exchange When Myeloma Presents as Acute Renal Failure. 143:777-777. 2005
Immune Thrombocytopenia Associated with Efalizumab Therapy for Psoriasis. 143:761-761. 2005
Endovascular and open repair did not differ for mortality rates at 2 years in abdominal aortic aneurysm. 143:64-64. 2005
How should clinicians interpret results reflecting the effect of an intervention on composite endpoints: Should I dump this lump?. 143:A8-A8. 2005
Alendronate reduced clinical and radiographic vertebral fractures in postmenopausal women with osteopenia. 143:46-46. 2005
Intensive insulin-glucose infusion regimens with long-term or standard glucose control did not differ for reducing mortality in type 2 diabetes mellitus and MI. 143:43-43. 2005
Low-dose aspirin lowered stroke risk but not risk for MI or cardiovascular death in women. 143:33-33. 2005
Review: Low-dose dopamine does not reduce mortality or need for renal replacement therapy. 143:42-42. 2005
Warfarin was not more effective than aspirin and increased adverse events in symptomatic intracranial arterial stenosis. 143:32-32. 2005
Use of a Clinical Prediction Score in Patients with Suspected Deep Venous Thrombosis: Two Steps Forward, One Step Back?. 143:140-140. 2005
Clinical Experience and Quality of Health Care. 143:85-85. 2005
Patient self-management of anticoagulants reduced arterial thromboembolism and adverse effects. 143:8-8. 2005
Prophylactic coronary artery revascularization before elective vascular surgery did not improve long-term survival. 143:12-12. 2005
Review: Population-based screening for abdominal aortic aneurysm reduces cause-specific mortality in older men. 143:11-11. 2005
Challenges in Systematic Reviews That Evaluate Drug Efficacy or Effectiveness. 142:1066-1066. 2005
Does clinical experience make up for failure to keep up to date?. 142:A8-A8. 2005
A Randomized Trial of Diagnostic Strategies after Normal Proximal Vein Ultrasonography for Suspected Deep Venous Thrombosis: d-Dimer Testing Compared with Repeated Ultrasonography. 142:490-490. 2005
Meta-Analysis: Low-Dose Dopamine Increases Urine Output but Does Not Prevent Renal Dysfunction or Death. 142:510-510. 2005
Reduced glomerular filtration rate was associated with increased death, cardiovascular events, and hospitalization. 142:50-50. 2005
Renal impairment increased mortality and cardiovascular complications after myocardial infarction. 142:51-51. 2005
Review: Glucocorticoids reduced mortality in sepsis in recent (post-1997) but not previous (pre-1989) trials, or all trials combined. 142:31-31. 2005
Review: Low-dose but not high-dose corticosteroids reduced all-cause mortality in severe sepsis and septic shock. 142:30-30. 2005
Decisions about Treating Community-Acquired Pneumonia. 142:215-215. 2005
Glycemia and Risk for Cardiovascular Disease. 142:227-227. 2005
Glycemia and Risk for Cardiovascular Disease. 142:227-227. 2005
Finding the gold in MEDLINE: Clinical Queries. 142:A8-A8. 2005
Methylprednisolone caused an increase in death after head injury. 142:5-5. 2005
Rapid measurement of B-type natriuretic peptides reduced time to discharge and treatment costs in patients with acute dyspnea. 142:A14-A14. 2005
Volunteers trained in CPR and use of automated external defibrillators increased survival after out-of-hospital cardiac arrest. 142:2-2. 2005
Cost-Effectiveness of Rhythm versus Rate Control in Atrial Fibrillation. 141:653-653. 2004
Fondaparinux was as effective as (noninferior to) enoxaparin in acute symptomatic deep venous thrombosis. 141:74-74. 2004
Perioperative use of atorvastatin reduced cardiovascular events in patients having vascular surgery. 141:64-64. 2004
Glycosylated Hemoglobin: Finally Ready for Prime Time as a Cardiovascular Risk Factor. 141:475-475. 2004
Low-Molecular-Weight Heparin for Pulmonary Embolism. 141:407-407. 2004
Low-Molecular-Weight Heparin for Pulmonary Embolism. 141:407-407. 2004
Doubling the dose of inhaled corticosteroids during asthma deterioration did not improve asthma control. 141:37-37. 2004
Fluid resuscitation with albumin or saline in the intensive care unit did not affect 28-day mortality rates. 141:29-29. 2004
Evidence-Based Clinical Practice Guideline for the Prevention of Ventilator-Associated Pneumonia. 141:305-305. 2004
Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding. 141:78-78. 2004
Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding. 141:80-80. 2004
Valsartan plus captopril did not improve survival more than captopril alone after myocardial infarction. 141:3-3. 2004
Vasopressin was not better than epinephrine for out-of-hospital cardiac arrest. 141:2-2. 2004
Association of Statin Therapy with Outcomes of Acute Coronary Syndromes: The GRACE Study. 140:857-857. 2004
Acpjc.org adds enhanced searching to many other features. 140:A13a-A13a. 2004
Campaign to revitalize academic medicine. 140:A13b-A13b. 2004
Estrogen plus progestin reduced risk for fracture in postmenopausal women. 140:61-61. 2004
Suboptimal Monitoring and Dosing of Unfractionated Heparin. 140:582-582. 2004
Randomized Trial of Warfarin Nomograms. 140:488-488. 2004
Randomized trial of warfarin nomograms.. 140:490-491. 2004
High- and moderate-intensity warfarin regimens did not differ for preventing thrombosis in the antiphospholipid antibody syndrome. 140:38-38. 2004
Noninvasive ventilation reduced duration of mechanical ventilation and ICU stay more than conventional weaning. 140:35-35. 2004
Low-Molecular-Weight Heparin Compared with Intravenous Unfractionated Heparin for Treatment of Pulmonary Embolism. 140:175-175. 2004
34% mortality rate from SARS in critically ill patients at 28 days in Toronto. 140:20-20. 2004
37% mortality rate from SARS in critically ill patients at 28 days in Singapore. 140:21-21. 2004
Patients at the center: In our practice, and in our use of language. 140:A11-A11. 2004
Rapid measurement of B-type natriuretic peptides reduced time to discharge and treatment costs in patients with acute dyspnea/COMMENTARY. 141:35-35. 2004
Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism. 139:893-893. 2003
Enalapril reduced the risk for new-onset diabetes in left ventricular dysfunction. 139:68-68. 2003
Low-intensity warfarin therapy prevented recurrent venous thromboembolism. 139:42-42. 2003
A win–win proposition: help us to build better evidence-based information systems for you. 139:A13-A13. 2003
Review: Debridement using hydrogel seems to be better than standard wound care for healing diabetic foot ulcer. 139:16-16. 2003
Routine Tandem Transplantation for Patients with Myeloma. 139:w-55. 2003
Which Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Benefit from Noninvasive Positive-Pressure Ventilation?. 138:861-861. 2003
A Diagnostic Strategy Involving a Quantitative Latex d-Dimer Assay Reliably Excludes Deep Venous Thrombosis. 138:787-787. 2003
Suboptimal Monitoring and Dosing of Unfractionated Heparin in Comparative Studies with Low-Molecular-Weight Heparin. 138:720-720. 2003
Review: MTHFR TT genotype increases risk for coronary heart disease. 138:79-79. 2003
Oral Vitamin K for Warfarin-Associated Coagulopathy. 138:611-611. 2003
Oral vitamin K for warfarin-associated coagulopathy.. 138:610-611. 2003
Homocysteine-lowering therapy improved outcomes after percutaneous coronary intervention. 138:33-33. 2003
Congenital Thrombophilic States Associated with Venous Thrombosis: A Qualitative Overview and Proposed Classification System. 138:128-128. 2003
The Memory Impairment Screen more accurately screened for Alzheimer disease than the 3-word memory test in older adults. 138:25-25. 2003
Successful Discontinuation of Therapy for Disseminated Mycobacterium avium Complex Infection after Effective Antiretroviral Therapy. 137:734-734. 2002
Colloid Use in the Critically Ill. 137:370-370. 2002
Colloid Use in the Critically Ill. 137:370-370. 2002
Oral Vitamin K Lowers the International Normalized Ratio More Rapidly Than Subcutaneous Vitamin K in the Treatment of Warfarin-Associated Coagulopathy. 137:251-251. 2002
Questioning the Treatment of Venous Thromboembolism. 137:144-144. 2002
Questioning the Treatment of Venous Thromboembolism. 137:145-145. 2002
Review: Extended out-of-hospital prophylaxis with heparin prevents deep venous thrombosis in elective hip arthroplasty. 137:11-11. 2002
Abciximab plus stenting reduced coronary events in patients with acute myocardial infarction. 136:89-89. 2002
Irbesartan was renoprotective in patients with type 2 diabetes, hypertension, and microalbuminuria. 136:82-82. 2002
Cardiovascular Outcomes and Renal Disease. 136:633-633. 2002
Cardiovascular Outcomes and Renal Disease. 136:634-634. 2002
The Role of High-Dose Chemotherapy and Stem-Cell Transplantation in Patients with Multiple Myeloma: A Practice Guideline of the Cancer Care Ontario Practice Guidelines Initiative. 136:619-619. 2002
Helicobacter pylori Eradication Therapy for Nonulcer Dyspepsia. 136:555-555. 2002
Rule-based computerized reminders increased ordering of preventive services in an inpatient setting. 136:74-74. 2002
Chemotherapy for Older Patients with Newly Diagnosed, Advanced-Stage, Aggressive-Histology Non-Hodgkin Lymphoma. 136:144-144. 2002
Clinical expertise in the era of evidence-based medicine and patient choice.. 136:A11-A14. 2002
Irbesartan reduced progression of nephropathy caused by type 2 diabetes independent of the effect on blood pressure.. 136:82-84. 2002
Review: Albumin administration is not associated with excess mortality in acutely ill patients. 136:2-2. 2002
“Double blind, you are the weakest link—good-bye!”. 136:A11-A11. 2002
Recombinant human activated protein C reduced all-cause mortality in patients with severe sepsis. 135:81-81. 2001
Venous Limb Gangrene during Warfarin Treatment of Cancer-Associated Deep Venous Thrombosis. 135:589-589. 2001
Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis. 135:502-502. 2001
Intravenous and Oral Itraconazole versus Intravenous Amphotericin B Deoxycholate as Empirical Antifungal Therapy for Persistent Fever in Neutropenic Patients with Cancer Who Are Receiving Broad-Spectrum Antibacterial Therapy. 135:412-412. 2001
Colloid Use for Fluid Resuscitation: Evidence and Spin. 135:205-205. 2001
Management of Suspected Deep Venous Thrombosis in Outpatients by Using Clinical Assessment and d-dimer Testing. 135:108-108. 2001
Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial. 134:629-629. 2001
Clinical Trials That Have Influenced the Treatment of Venous Thromboembolism: A Historical Perspective. 134:409-409. 2001
The rocky road: qualitative research as evidence.. 134:A11-A13. 2001
Erythropoietin with Iron Supplementation To Prevent Allogeneic Blood Transfusion in Total Hip Joint Arthroplasty. 133:845-845. 2000
Effect of a Preoperative Intervention on Preoperative and Postoperative Outcomes in Low-Risk Patients Awaiting Elective Coronary Artery Bypass Graft Surgery. 133:253-253. 2000
Controlled- and extended-release metoprolol reduced mortality in congestive heart failure. 133:3-3. 2000
Ardeparin Sodium for Extended Out-of-Hospital Prophylaxis against Venous Thromboembolism after Total Hip or Knee Replacement. 132:853-853. 2000
A multidisciplinary, home-based intervention reduced deaths and readmissions in patients with chronic congestive heart failure. 132:88-88. 2000
Homocyst(e)ine and Cardiovascular Disease. 132:676-676. 2000
Homocyst(e)ine and Cardiovascular Disease. 132:676-676. 2000
Use of Statins and Fibrates in Hyperlipidemic Patients with Neuromuscular Disorders. 132:418-418. 2000
Controlled- and extended-release metoprolol reduced mortality in congestive heart failure. 132:2-2. 2000
Controlled- and extended-release metoprolol reduced mortality in congestive heart failure. 132:3-3. 2000
Systemic Amyloidosis Presenting with Angina Pectoris. 131:838-838. 1999
Interpreting, Integrating, and Individualizing Evidence about the Prevention of Diabetic Nephropathy. 131:707-707. 1999
Clinical Utility of a Rapid Whole-Bloodd-Dimer Assay in Patients with Cancer Who Present with Suspected Acute Deep Venous Thrombosis. 131:417-417. 1999
Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence. 131:363-363. 1999
Bisoprolol reduced all-cause mortality, cardiovascular mortality, and hospitalization in CHF. 131:5-5. 1999
Ventilator-Associated Pneumonia in Critically Ill Patients. 130:1028-1028. 1999
Intensive blood glucose control reduced type 2 diabetes mellitus-related end points. 130:2-2. 1999
Metformin reduced diabetes-related end points and all-cause mortality in overweight patients with type 2 diabetes. 130:3-3. 1999
Sensitivity and Specificity of a Rapid Whole-Blood Assay for D-Dimer in the Diagnosis of Pulmonary Embolism. 129:1006-1006. 1998
The Role of Venous Ultrasonography in the Diagnosis of Suspected Deep Venous Thrombosis and Pulmonary Embolism. 129:1044-1044. 1998
Use of a Clinical Model for Safe Management of Patients with Suspected Pulmonary Embolism. 129:997-997. 1998
Incidence of and Risk Factors for Ventilator-Associated Pneumonia in Critically Ill Patients. 129:433-433. 1998
The Ineffectiveness of Immunosuppressive Therapy in Lymphocytic Myocarditis: An Overview. 129:317-317. 1998
Coenzyme A Reductase Inhibitors and Stroke. 129:161-161. 1998
Coenzyme A Reductase Inhibitors and Stroke. 129:162-162. 1998
Noninvasive Diagnosis of Deep Venous Thrombosis. 128:663-663. 1998
Locating and Appraising Systematic Reviews. 128:322-322. 1998
Locating and Appraising Systematic Reviews. 128:323-323. 1998
Relation of Factor V Leiden Genotype to Risk for Acute Deep Venous Thrombosis after Joint Replacement Surgery. 128:270-270. 1998
Effect of HMGcoA Reductase Inhibitors on Stroke. 128:89-89. 1998
Using 'Best Evidence' in clinical practice.. 128:A15. 1998
Fish consumption in men decreased nonsudden death from MI. 127:80-80. 1997
The Pathogenesis of Venous Limb Gangrene Associated with Heparin-Induced Thrombocytopenia. 127:804-804. 1997
Selecting and Appraising Studies for a Systematic Review. 127:531-531. 1997
Antileukotrienes in the Treatment of Asthma. 127:472-472. 1997
Reply: Warfarin: Less May Be Better. 127:333-333. 1997
The Relation between Systematic Reviews and Practice Guidelines. 127:210-210. 1997
Splenectomy for Relapsing Thrombotic Thrombocytopenic Purpura. 126:915-915. 1997
Transferring evidence from research into practice: 4. Overcoming barriers to application. 126:A14-A14. 1997
Locating and Appraising Systematic Reviews. 126:532-532. 1997
Dietary Calcium and Blood Pressure. 126:492-492. 1997
Subcutaneous tunneling reduced catheter-related sepsis in critically ill patients. 126:42-42. 1997
Systematic Reviews: Critical Links in the Great Chain of Evidence. 126:389-389. 1997
Systematic Reviews: Synthesis of Best Evidence for Clinical Decisions. 126:376-376. 1997
Transferring evidence from research into practice: 3. Developing evidence-based clinical policy. 126:A14-A14. 1997
Diagnosis and Treatment of Idiopathic Thrombocytopenic Purpura: Recommendations of the American Society of Hematology. 126:319-319. 1997
Comparison of 5-mg and 10-mg Loading Doses in Initiation of Warfarin Therapy. 126:133-133. 1997
Transferring evidence from research into practice: 2. Getting the evidence straight. 126:A14-A14. 1997
Transferring evidence from research into practice: 1. The role of clinical care research evidence in clinical decisions. 125:A14-A14. 1996
Splenectomy Done during Hematologic Remission To Prevent Relapse in Patients with Thrombotic Thrombocytopenic Purpura. 125:294-294. 1996
Quinolone-Based Antibacterial Chemoprophylaxis in Neutropenic Patients: Effect of Augmented Gram-Positive Activity on Infectious Morbidity. 125:183-183. 1996
Enteral feeding by endoscopic gastrostomy reduced 6-week mortality after dysphagic stroke. 125:5-5. 1996
Beyond ACP Journal Club: how to harness MEDLINE for review articles. 124:A12-A12. 1996
Once-Daily Aminoglycoside Dosing in Immunocompetent Adults. 124:717-717. 1996
Insulin infusion followed by multiple daily insulin injections reduced mortality after MI in diabetes. 124:1-1. 1996
The Antioxidant Vitamins and Cardiovascular Disease: A Critical Review of Epidemiologic and Clinical Trial Data. 123:860-860. 1995
Endoscopic Ligation Compared with Sclerotherapy for Treatment of Esophageal Variceal Bleeding. 123:280-280. 1995
Beyond ACP Journal Club: how to harness MEDLINE for prognosis problems. 123:A12-A12. 1995
Late Relapses in Patients Successfully Treated for Thrombotic Thrombocytopenic Purpura. 122:569-569. 1995
Applying the findings of clinical trials to individual patients. 122:A12-A12. 1995
Accuracy of Ultrasound for the Diagnosis of Deep Venous Thrombosis in Asymptomatic Patients after Orthopedic Surgery. 122:47-47. 1995
How should clinicians use the results of randomized trials?. 122:A12-A12. 1995
Beyond ACP Journal Club: how to harness MEDLINE for etiology problems. 121:A10-A10. 1994
Interactions of Warfarin with Drugs and Food. 121:676-676. 1994
Analyzing Computer-based Decision Support Systems. 121:469-469. 1994
Can Bruits Distinguish High-Grade from Moderate Symptomatic Carotid Stenosis?. 120:633-633. 1994
Thrombocytopenia and Illicit Drug Use. 120:693-693. 1994
Beyond ACP Journal Club: how to harness MEDLINE to solve clinical problems. 120:A10-2. 1994
Glycogen Storage Disease in Adults. 120:218-218. 1994
Effects of Computer-based Clinical Decision Support Systems on Clinician Performance and Patient Outcome: A Critical Appraisal of Research. 120:135-135. 1994
Monitoring Heparin Therapy. 120:169-169. 1994
Efficacy and Cost of Low-Molecular-Weight Heparin Compared with Standard Heparin for the Prevention of Deep Vein Thrombosis after Total Hip Arthroplasty. 119:1105-1105. 1993
Screening for Abdominal Aortic Aneurysm in Men Ages 60 to 80 Years: A Cost-Effectiveness Analysis. 119:411-411. 1993
Impedance Plethysmography and DVT Diagnosis. 119:246-246. 1993
Establishing a Therapeutic Range for Heparin Therapy. 119:104-104. 1993
Clinical judgment was inaccurate for the diagnosis and treatment of ventilator-associated pneumonia in ICU patients who needed mechanical ventilation. 119:22-22. 1993
Measuring Health-Related Quality of Life. 118:622-622. 1993
Incidence of Postpartum Thyroid Dysfunction in Patients with Type I Diabetes Mellitus. 118:419-419. 1993
Eliciting Patient Preferences. 118:76-76. 1993
Eliciting patient preferences.. 118:76. 1993
Limitations of Impedance Plethysmography in the Diagnosis of Clinically Suspected Deep-Vein Thrombosis. 118:25-25. 1993
Thrombosis in Antithrombin-III Deficiency. 117:875-875. 1992
A Low-Molecular-Weight Heparinoid Compared with Unfractionated Heparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke. 117:353-357. 1992
Subcutaneous compared with intravenous heparin for deep vein thrombosis.. 117:266. 1992
A Bedside Decision Instrument To Elicit a Patient's Preference Concerning Adjuvant Chemotherapy for Breast Cancer. 117:53-58. 1992
Splenic Radiation for Corticosteroid-resistant Immune Thrombocytopenia. 116:977-981. 1992
Failure of Aspirin plus Dipyridamole To Prevent Restenosis after Carotid Endarterectomy. 116:731-736. 1992
Thrombosis in Antithrombin-III-deficient Persons. 116:754-761. 1992
A Consumer's Guide to Subgroup Analyses. 116:78-84. 1992
How Should Results from Completed Studies Influence Ongoing Clinical Trials?. 115:818-822. 1991
Relapse frequently occurred in Graves disease after treatment. 115:91-91. 1991
Stroke Prevention in Nonvalvular Atrial Fibrillation. 115:727-736. 1991
LMW Heparin for Deep Vein Thrombosis. 115:231-232. 1991
Intensified insulin increased the risk for serious hypoglycemia and neuroglycopenia in IDDM. 114:84-84. 1991
Prevention of Deep Vein Thrombosis after Elective Hip Surgery. 114:545-551. 1991
Loose Connections between Peer-Reviewed Clinical Journals and Clinical Practice. 113:724-724. 1990
More Informative Abstracts Revisited. 113:69-69. 1990
Then-of-1 Randomized Controlled Trial: Clinical Usefulness. 112:293-293. 1990
Online Access to MEDLINE in Clinical Settings. 112:78-78. 1990
Medical Therapy for Chronic Congestive Heart Failure. 110:758-758. 1989
Neuropsychiatric Hirsuitism. 110:748-748. 1989
Campylobacter pylori Infection. 109:925-925. 1988
Pulmonary Hypertension in Hemophilia. 109:759-759. 1988
Somatostatin Treatment for Cryptosporidial Diarrhea in a Patient with the Acquired Immunodeficiency Syndrome (AIDS). 108:708-708. 1988
Correction: Omitted Author's Name. 108:496-496. 1988
Increased Neutrophil Elastase Activity in Cigarette Smokers. 107:680-680. 1987
Adjusted Subcutaneous Heparin or Continuous Intravenous Heparin in Patients with Acute Deep Vein Thrombosis. 107:441-441. 1987
Superiority of Alternating Non-Cross-Resistant Chemotherapy in Extensive Small Cell Lung Cancer. 107:451-451. 1987
Bicarbonate in Severe Lactic Acidosis. 107:258-258. 1987
Health Economics: An Introduction for Clinicians. 107:88-88. 1987
A Proposal for More Informative Abstracts of Clinical Articles. 106:598-598. 1987
Correction: How to Keep Up with the Medical Literature. 106:174-174. 1987
Canadian Cancer Care: Organizational Models. 105:932-932. 1986
How to Keep Up with the Medical Literature: VI. How to Store and Retrieve Articles Worth Keeping. 105:978-978. 1986
Intravenous heparin for the prevention of stroke progression in acute partial stable stroke.. 105:825-828. 1986
How to Keep Up with the Medical Literature: V. Access by Personal Computer to the Medical Literature. 105:810-810. 1986
How to Keep Up with the Medical Literature: IV. Using the Literature to Solve Clinical Problems. 105:636-636. 1986
Is Bone Marrow Examination in Small-Cell Lung Cancer Really Necessary?. 105:508-508. 1986
How to Keep Up with the Medical Literature: III. Expanding the Number of Journals You Read Regularly. 105:474-474. 1986
Searching the Medical Literature. 105:472-472. 1986
How to Keep Up with the Medical Literature: II. Deciding Which Journals to Read Regularly. 105:309-309. 1986
Seroconversion After Hepatitis B Vaccination. 105:293-293. 1986
How to Keep Up with the Medical Literature: I. Why Try to Keep Up and How to Get Started. 105:149-149. 1986
Computer Searching of the Medical Literature. 104:723-723. 1986
Computer Searching of the Medical Literature. 103:812-812. 1985
Platelet-Aggregating Factor in Thrombotic Thrombocytopenic Purpura. 102:560-560. 1985
Malignant Lymphoma Presenting as Kaposi's Sarcoma in a Homosexual Man with the Acquired Immunodeficiency Syndrome. 102:338-338. 1985
Diagnostic Efficacy of Impedance Plethysmography for Clinically Suspected Deep-Vein Thrombosis. 102:21-21. 1985
Detection of a Platelet-Agglutinating Factor in Thrombotic Thrombocytopenic Purpura. 101:589-589. 1984
Lidocaine Therapy with an Exponentially Declining Infusion. 101:632-632. 1984
Changes in Body Composition in Patients with Small-Cell Lung Cancer. 101:303-303. 1984
Choice of Platelet Anticoagulants. 100:613-613. 1984
Heparin-Associated Thrombocytopenia. 100:535-535. 1984
Management of the Pregnant Patient with Idiopathic Thrombocytopenic Purpura. 99:796-796. 1983
Pulmonary Angiography, Ventilation Lung Scanning, and Venography for Clinically Suspected Pulmonary Embolism with Abnormal Perfusion Lung Scan. 98:891-891. 1983
Effect of Digoxin on Right Ventricular Function in Severe Chronic Airflow Obstruction. 95:283-283. 1981
Replacement of Venography in Suspected Venous Thrombosis by Impedance Plethysmography and¹²⁵I-Fibrinogen Leg Scanning. 94:12-12. 1981
Herpes Zoster in Patients with Small-Cell Carcinoma of the Lung Receiving Combined Modality Treatment. 93:282-282. 1980
Gentamicin Hemodialysis. 92:709-709. 1980
Comparison of Chemical Composition of Peritoneal Fluid and Serum. 89:67-67. 1978
Drinking Water Hardness and Urolithiasis. 88:513-513. 1978
The Burlington Randomized Trial of the Nurse Practitioner: Health Outcomes of Patients. 80:137-137. 1974
Thrombolytic Therapy and Fatal Pulmonary Emboli. 75:140-140. 1971
Death and Disability in Drug Addiction and Abuse. 67:205-205. 1967
RENAL HOMOTRANSPLANTATION; LATE FUNCTION AND COMPLICATIONS.. 61:470-497. 1964
THE MANAGEMENT OF BILIARY TRACT DISORDERS IN PATIENTS WITH HEART DISEASE. 39:484-484. 1953
Safety and Effectiveness of Long-Acting Inhaled β-Agonist Bronchodilators When Taken with Inhaled Corticosteroids 2006

ACP journal club Journal

Overview

publication venue for

has subject area

Identity

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)